Lacutamab Biosimilar – Anti-KIR3DL2 mAb – Research Grade

Reference:
Product nameLacutamab Biosimilar - Anti-KIR3DL2 mAb - Research Grade
SourceCAS 2187368-16-5
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsLacutamab ,IPH4102,KIR3DL2,anti-KIR3DL2
ReferencePX-TA1364
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Lacutamab Biosimilar - Anti-KIR3DL2 mAb - Research Grade

General information on Anti-KIR3DL2[Homo sapiens] (Lacutamab ) Monoclonal Antibody

Lacutamab is investigatedfor the treatment of Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL).

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Lacutamab Biosimilar – Anti-KIR3DL2 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD158k / KIR3DL2, C-Fc, recombinant protein
Antigen

CD158k / KIR3DL2, C-Fc, recombinant protein

PX-P5580 385€
Stable Isotope Labelled Lacutamab  Biosimilar – Anti-KIR3DL2 mAb – Research Grade
SIL

Stable Isotope Labelled Lacutamab Biosimilar – Anti-KIR3DL2 mAb – Research Grade

PX-TA1364-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products